Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AMD vs OTLK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMD Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

AMD Overall Winner 6-Pillar Tally: AMD 5 – 1 OTLK Matrix Metrics: AMD 6 – 4 OTLK

As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Outlook Therapeutics, Inc. (OTLK) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). AMD carries a Unified Composite Score of 48.9/100 (HOLD) at $508.41 (30.2x Forward P/E, 17.8% operating margin), whereas OTLK carries 48.6/100 (HOLD) at $0.40 (2.9x Forward P/E, 4781.8% operating margin).

  • Technical & Structure Timing Caution: AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 47.0); meanwhile OTLK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMD vs OTLK
AMD NASDAQ Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
$508.41
-4.8% 1D
Market Cap $959.9B
TTM Revenue $45.4B
Forward P/E 30.2x
Beta / 30D Vol 3.60β · 118% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 23.0 Fund 42.0 Flow 68.0 Mom 37.6
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.0 · SMA20: $517.43 · SMA50: $555.12
OTLK NASDAQ
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap $107.1M
TTM Revenue N/A
Forward P/E 2.9x
Beta / 30D Vol 1.47β · 79% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 71.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 31
RSI-14: 31.2 · SMA20: $0.48 · SMA50: $0.56

6-Pillar Scorecard Institutional Category Breakdown (AMD 5 – 1 OTLK)

Columns: Metric · AMD · OTLK
1. Valuation Multiples OTLK
Forward P/E 30.2x 2.9x
Trailing P/E 125.1x 2.9x
PEG Ratio 0.50x N/M
EV / Revenue 21.2x N/M
2. Growth & Scale AMD
Revenue Growth (YoY) +44.7% -99.4%
Earnings Growth (YoY) +93.8% +0.0%
TTM Revenue (USD) $45.4B N/A
Market Cap $959.9B $107.1M
3. Profitability & Quality AMD
Gross Margin 56.0% N/A
Operating Margin 17.8% 4781.8%
Net Profit Margin 16.8% 0.0%
Return on Equity (ROE) 12.0% -3.6%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) $7.06B -$56M
Cash Flow Margin 15.5% N/A
Net Cash / Leverage $1.51B Net Debt (0.13x D/E) $7.2M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 78.1% (10th %ile) 181.3% (55th %ile)
Put/Call OI Skew 1.07x (Balanced) 0.26x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity 38.2% of Rev ($17.4B) N/A
90D R&D Disclosures 7 papers 0 papers
Competitive Moat Concentrated Oligopoly Moat High-Margin Pricing Power Moat
Supply-Chain Role AI Accelerator & Server Chiplet Designer Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMD (6) vs OTLK (4)
Institutional Metric AMD OTLK Criterion Row Edge
Market Capitalization
Scale
$959.9B $107.1M Larger Scale AMD
Trailing P/E Ratio
Valuation
125.1x 2.9x Lower Multiple OTLK
Forward P/E Ratio
Valuation
30.2x 2.9x Lower Multiple OTLK
Revenue Growth (YoY)
Growth
+44.7% -99.4% Higher Growth AMD
Operating Margin (TTM)
Profitability
17.8% 4781.8% Higher Margin OTLK
Net Profit Margin
Profitability
16.8% 0.0% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
12.0% -3.6% Higher ROE AMD
52-Week Range Position
Momentum
68% ($188–$659) 10% ($0–$3) Stronger Trend AMD
Beta / 30D Volatility
Risk Regime
3.60β · 118% Vol 1.47β · 79% Vol Lower Realized Risk OTLK
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 48.6 / 100 (HOLD) Higher Composite AMD
Trailing 12M Revenue (USD)
Operating Scale
$45.4B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
56.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.50x PEG · 21.2x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.06B ($1.51B Net Debt (0.13x D/E)) -$56M ($7.2M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMD +14.97 pp
AMD: -3.85% · OTLK: -18.82%
3M Horizon AMD +48.35 pp
AMD: +4.96% · OTLK: -43.39%
6M Horizon OTLK +52.14 pp
AMD: +20.77% · OTLK: +72.91%
1Y Horizon AMD +178.08 pp
AMD: +105.04% · OTLK: -73.04%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AMD Revenue OTLK Revenue AMD Op. Margin OTLK Op. Margin Margin Leader
FY2018 $6.47B $0M 7.0% -960.1% AMD
FY2019 $6.73B $10M 9.4% -445.6% AMD
FY2020 $9.76B N/A 14.0% N/A AMD
FY2021 $16.4B N/A 22.2% N/A AMD
FY2022 $23.6B N/A 5.4% N/A AMD
FY2023 $22.7B N/A 1.8% N/A AMD
FY2024 $25.8B N/A 7.4% N/A AMD
FY2025 $34.6B $0M 10.7% -4744.3% AMD

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMD CONSOLIDATION
103d in phase · OBV ACCUMULATION
Current IV 78.1%
IV Percentile 10th %ile
Put/Call OI Skew 1.07x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor $500.00
Call Wall Magnet $600.00
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Put Floor: $500.00 (-1.7%) Spot: $508.41 Call Magnet: $600.00 (+18.0%)
  • Extended consolidation (103 days)
  • IV expanding (+13.4%) - uncertainty/bearish
  • Near put wall support ($500)
OTLK BREAKDOWN
103d in phase · OBV NEUTRAL
Current IV 181.3%
IV Percentile 55th %ile
Put/Call OI Skew 0.26x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact OTLK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models
OTLK Moat Profile High-Margin Pricing Power Moat
Biotechnology Operator
Competes within the Biotechnology value chain with $107.1M market capitalization and 4781.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AMD vs OTLK Key Questions & Quantitative Answers

As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Outlook Therapeutics, Inc. (OTLK) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). AMD carries a Unified Composite Score of 48.9/100 (HOLD) at $508.41 (30.2x Forward P/E, 17.8% operating margin), whereas OTLK carries 48.6/100 (HOLD) at $0.40 (2.9x Forward P/E, 4781.8% operating margin). Technical & Structure Timing Caution: AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 47.0); meanwhile OTLK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMD leads the Growth & Scale pillar: AMD posts +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin), compared with OTLK at -99.4% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 4781.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AMD cumulative revenue shifted +435.4% while OTLK shifted N/A. In operating R&D and SG&A reinvestment, AMD deploys 38.2% of Rev ($17.4B) (7 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OTLK.

OTLK screens cheaper on headline valuation multiples. AMD trades at 30.2x Forward P/E, 125.1x Trailing P/E, 0.50x PEG, and 21.2x EV/Revenue (15.5% FCF margin), whereas OTLK trades at 2.9x Forward P/E, 2.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMD (12.0% ROE) versus OTLK (-3.6% ROE) capital efficiency.

In options market volatility and institutional positioning, AMD carries 78.1% implied volatility (10th %ile, Compressed (<25th %ile)), a 1.07x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.60β · 118% Vol realized risk). By comparison, OTLK carries 181.3% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.26x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.47β · 79% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.